United Therapeutics diskutieren
United Therapeutics
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
327,60 €
4,90 %
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $300.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at HC Wainwright from $300.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target lowered by analysts at Bank of America Co. from $303.00 to $280.00. They now have an "underperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $350.00 to $380.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $400.00 to $575.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Neueste Beiträge
BTIG_Research in Integra LifeSciences Holdings Corp diskutieren